Review
Year 2016,
Volume: 8 Issue: 2, 59 - 69, 30.03.2016
Abstract
Kanser tip bilimi için büyük sorun olmaya devam etmektedir. Mevcut tedaviler genellikle
bu hastalığa ilişkin sorunları çözmekte yetersiz kalmaktadır. Kanser aşıları kanser alanında
en son keşiftir. Kanser aşılarının amacı kanser hücrelerini anormal olarak tanıyabilmeleri
be yıkmaları için immün sistemi uyarmaktır. Çoğunlukla, kanser aşı araştırmalarının
genel aşı ya da bir kanser tipine özgü aşı geliştirme şeklinde 2 tipi vardır. kanser aşıları
için, peptidler, proteinler, antijen sunan hücreler, tümör hücreleri ve viral vektörleri
içeren pek çok platform test edilmektedir. Günümüzde n2 kanser aşısı FDA tarafından onaylanmıştır.
Preklinik ve klinik çalışmaları devam eden pek çok kanser aşısı vardır.
Keywords
References
- 1. World Health Organization. The top causes of death. Fact sheets no: 310. http://www.who.int/mediacentre/factsheets/fs310/en/index2.html. Erişim tarihi: 15.06.2015 2. World Health Organization. Cancer fact sheet. 2015. Erişim. www.who.int/mediacentre/factsheets/ fs297/en/. Erişim tarihi: 15.06.2015 3. Jaganti V, Das S, Sampath TS. A review on cancer vaccines. International Journal of Pharma and Bio Sciences. 2011;2(3):86-98. 4. European Parliament, Scientific Technology Options Assessment (STOA), Gene, Vaccine and Immunotherapies against Cancer: New Approaches to an Old Problem, Results of the Project “Future Development of Cancer Therapy” IPOL/A/STOA/ST/2006-21 p.1- 5. Kumar VP, Prasanthi S, Lakshmi VRS, Sai Santosh MV. Cancer Vaccines: A Promising Role in Cancer Therapy. Acad. J. Cancer Res.2010; 3 (2): 16-21, 6. Butterfield LH. Cancer vaccines. BMJ 2015;350:h988- 7. Guo C, Manjili MH, Subjeck JR, Sarkar D et al. Therapeutic Cancer Vaccines: Past, Present and Future. Adv Cancer Res. 2013; 119: 421–475. 8. Becker MD, Dally J, Martini J. Cancer Vaccine Therapies: Failures and Future Opportunities. MD Becker Partners LLC www.mdbpartners.com 9. Ribas A, Butterfield LH, Glaspy JA; Economou JS. Current Developments in Cancer Vaccines and Cellular Immunotherapy. J Clin Oncology, 2003;21(12): 2415-2432 10. Disis ML, Morse MA, Weber JS. Therapeutic Cancer Vaccines: Targeting the Future of Cancer Treatment. Expert Rev Vaccines. 2013;12(10):1219-1234. 11. Palucka K, Ueno H, Banchereau J. Recent Developments in Cancer Vaccines. J Immunol 2011; 186:1325-1331 12. Menaria J, Kitawat S, Verma V. Cancer Vaccine: An Overview. Sch. J. App. Med. Sci, 2013; 1(3):161-171 13. Melero I, Gaudernack G, Gerritsen W, Huber C et al. Therapeutic vaccines for cancer: an overview of clinical trials. Nature Reviews Clinical Oncology, 2014;11: 509–524.
Year 2016,
Volume: 8 Issue: 2, 59 - 69, 30.03.2016
Abstract
References
- 1. World Health Organization. The top causes of death. Fact sheets no: 310. http://www.who.int/mediacentre/factsheets/fs310/en/index2.html. Erişim tarihi: 15.06.2015 2. World Health Organization. Cancer fact sheet. 2015. Erişim. www.who.int/mediacentre/factsheets/ fs297/en/. Erişim tarihi: 15.06.2015 3. Jaganti V, Das S, Sampath TS. A review on cancer vaccines. International Journal of Pharma and Bio Sciences. 2011;2(3):86-98. 4. European Parliament, Scientific Technology Options Assessment (STOA), Gene, Vaccine and Immunotherapies against Cancer: New Approaches to an Old Problem, Results of the Project “Future Development of Cancer Therapy” IPOL/A/STOA/ST/2006-21 p.1- 5. Kumar VP, Prasanthi S, Lakshmi VRS, Sai Santosh MV. Cancer Vaccines: A Promising Role in Cancer Therapy. Acad. J. Cancer Res.2010; 3 (2): 16-21, 6. Butterfield LH. Cancer vaccines. BMJ 2015;350:h988- 7. Guo C, Manjili MH, Subjeck JR, Sarkar D et al. Therapeutic Cancer Vaccines: Past, Present and Future. Adv Cancer Res. 2013; 119: 421–475. 8. Becker MD, Dally J, Martini J. Cancer Vaccine Therapies: Failures and Future Opportunities. MD Becker Partners LLC www.mdbpartners.com 9. Ribas A, Butterfield LH, Glaspy JA; Economou JS. Current Developments in Cancer Vaccines and Cellular Immunotherapy. J Clin Oncology, 2003;21(12): 2415-2432 10. Disis ML, Morse MA, Weber JS. Therapeutic Cancer Vaccines: Targeting the Future of Cancer Treatment. Expert Rev Vaccines. 2013;12(10):1219-1234. 11. Palucka K, Ueno H, Banchereau J. Recent Developments in Cancer Vaccines. J Immunol 2011; 186:1325-1331 12. Menaria J, Kitawat S, Verma V. Cancer Vaccine: An Overview. Sch. J. App. Med. Sci, 2013; 1(3):161-171 13. Melero I, Gaudernack G, Gerritsen W, Huber C et al. Therapeutic vaccines for cancer: an overview of clinical trials. Nature Reviews Clinical Oncology, 2014;11: 509–524.
There are 1 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Internal Diseases |
| Journal Section | makaleler |
| Authors | |
| Publication Date | March 30, 2016 |
| Published in Issue | Year 2016 Volume: 8 Issue: 2 |
